Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MCS in Prostate Cancer Prevention
NCT02042807Phase 2Active, not recruiting
- Sponsor
- Health Ever Bio-Tech Co., Ltd.
- Start
- Oct 2014
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of MCS in prostate cancer (PCa), sponsored by Health Ever Bio-Tech Co., Ltd.. Started Oct 2014; status: active, not recruiting.
02
Drugs
MCS
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT02042807.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02042807.